K2M Group Holdings, Inc. (NASDAQ:KTWO) shares fell 7% during mid-day trading on Friday . The company traded as low as $20.50 and last traded at $20.66. 1,363,420 shares traded hands during mid-day trading, an increase of 246% from the average session volume of 394,223 shares. The stock had previously closed at $22.22.

A number of research firms have recently issued reports on KTWO. Royal Bank Of Canada reiterated a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research note on Thursday, July 20th. BidaskClub upgraded shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a research note on Wednesday, July 19th. Cowen and Company reiterated a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research note on Wednesday, July 19th. JMP Securities reiterated an “outperform” rating and issued a $30.00 target price (up previously from $27.00) on shares of K2M Group Holdings in a research note on Wednesday, June 28th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of K2M Group Holdings in a research note on Wednesday, August 2nd. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. K2M Group Holdings currently has a consensus rating of “Buy” and an average target price of $26.50.

The stock’s market capitalization is $893.92 million. The stock’s 50-day moving average price is $23.15 and its 200-day moving average price is $22.35.

K2M Group Holdings (NASDAQ:KTWO) last posted its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. The business had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the business posted ($0.27) EPS. On average, equities analysts forecast that K2M Group Holdings, Inc. will post ($0.78) EPS for the current fiscal year.

In related news, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total transaction of $56,588.00. Following the sale, the chief financial officer now owns 55,158 shares in the company, valued at approximately $1,328,204.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total transaction of $26,247.20. Following the sale, the insider now owns 201,961 shares in the company, valued at approximately $4,863,220.88. The disclosure for this sale can be found here. Insiders have sold a total of 45,085 shares of company stock worth $1,056,903 in the last quarter. 5.80% of the stock is currently owned by company insiders.

A number of large investors have recently modified their holdings of the stock. TimesSquare Capital Management LLC lifted its stake in K2M Group Holdings by 31.5% in the 2nd quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after purchasing an additional 691,000 shares during the last quarter. Wellington Management Group LLP lifted its stake in K2M Group Holdings by 10.4% in the 1st quarter. Wellington Management Group LLP now owns 1,875,913 shares of the medical device company’s stock valued at $38,475,000 after purchasing an additional 175,998 shares during the last quarter. Schroder Investment Management Group lifted its stake in K2M Group Holdings by 1.6% in the 2nd quarter. Schroder Investment Management Group now owns 1,560,340 shares of the medical device company’s stock valued at $37,401,000 after purchasing an additional 24,671 shares during the last quarter. Vanguard Group Inc. lifted its stake in K2M Group Holdings by 12.4% in the 2nd quarter. Vanguard Group Inc. now owns 1,550,592 shares of the medical device company’s stock valued at $37,772,000 after purchasing an additional 171,502 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in K2M Group Holdings by 54.3% in the 1st quarter. JPMorgan Chase & Co. now owns 1,409,360 shares of the medical device company’s stock valued at $28,906,000 after purchasing an additional 495,749 shares during the last quarter. 97.77% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This article was first published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/09/15/k2m-group-holdings-inc-ktwo-shares-down-7.html.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.